Detalles de la búsqueda
1.
Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant.
Leuk Lymphoma;
: 1-4, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557299
2.
[Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
32(2): 505-511, 2024 Apr.
Artículo
en Chino
| MEDLINE | ID: mdl-38660859
3.
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.
Discov Oncol;
15(1): 78, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502423
4.
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.
Front Oncol;
13: 1266868, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37799469
5.
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
BMC Cancer;
23(1): 980, 2023 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838670
6.
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment.
J Clin Med;
12(19)2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37834886
7.
Autologous stem cell transplantation in multiple myeloma patients with renal impairment.
Ann Hematol;
102(3): 621-628, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633638
8.
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Am J Hematol;
98(1): 66-78, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219502
9.
Clinical characteristics and prognostic analysis of acute myeloid leukemia patients with PTPN11 mutations.
Hematology;
27(1): 1184-1190, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36318614
10.
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.
Front Oncol;
12: 938392, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36276097
11.
Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.
Ann Hematol;
101(11): 2555-2557, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969250
12.
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma.
Ann Transl Med;
10(6): 298, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35433994
13.
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells.
J Hematol Oncol;
15(1): 39, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365211
14.
[The Role of Whole Body DWI in the Evaluation of Bone Disease in Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
30(2): 501-505, 2022 Apr.
Artículo
en Chino
| MEDLINE | ID: mdl-35395986
15.
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma.
Am J Hematol;
97(5): 537-547, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114022
16.
Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.
Leuk Lymphoma;
63(2): 491-494, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668450
17.
[Application of Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
29(6): 1831-1836, 2021 Dec.
Artículo
en Chino
| MEDLINE | ID: mdl-34893119
18.
[The Effects of Chidamide Combined with Anti-myeloma Drugs on the Proliferation and Apoptosis of Myeloma Cells].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
29(4): 1187-1194, 2021 Aug.
Artículo
en Chino
| MEDLINE | ID: mdl-34362501
19.
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia.
Clin Cancer Res;
27(20): 5492-5501, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253577
20.
Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma.
Cancer Med;
10(2): 563-574, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33356013